DK0842169T3 - Benzothiophenforbindelser - Google Patents

Benzothiophenforbindelser

Info

Publication number
DK0842169T3
DK0842169T3 DK96922500T DK96922500T DK0842169T3 DK 0842169 T3 DK0842169 T3 DK 0842169T3 DK 96922500 T DK96922500 T DK 96922500T DK 96922500 T DK96922500 T DK 96922500T DK 0842169 T3 DK0842169 T3 DK 0842169T3
Authority
DK
Denmark
Prior art keywords
acrylic
directed
propionic acid
benzothiophene
acid compounds
Prior art date
Application number
DK96922500T
Other languages
English (en)
Inventor
Charles D Jones
Alan D Palkowitz
Kenneth J Thrasher
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK0842169T3 publication Critical patent/DK0842169T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56—Radicals substituted by oxygen atoms
DK96922500T 1995-06-26 1996-06-25 Benzothiophenforbindelser DK0842169T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52095P 1995-06-26 1995-06-26
PCT/US1996/010551 WO1997001549A1 (en) 1995-06-26 1996-06-25 Benzothiophene compounds

Publications (1)

Publication Number Publication Date
DK0842169T3 true DK0842169T3 (da) 2001-01-29

Family

ID=21691867

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96922500T DK0842169T3 (da) 1995-06-26 1996-06-25 Benzothiophenforbindelser

Country Status (12)

Country Link
US (1) US6440958B1 (da)
EP (1) EP0842169B1 (da)
JP (1) JPH11508269A (da)
AT (1) ATE198477T1 (da)
AU (1) AU6335496A (da)
CA (1) CA2220991A1 (da)
DE (1) DE69611452T2 (da)
DK (1) DK0842169T3 (da)
ES (1) ES2153113T3 (da)
GR (1) GR3035492T3 (da)
PT (1) PT842169E (da)
WO (1) WO1997001549A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5827876A (en) * 1996-04-09 1998-10-27 American Home Products Corporation Inhibition of bone loss by 3-(4-acrylamidobenzoyl) benzo b!-thiophenes
CA2287993A1 (en) * 1997-04-30 1998-11-05 Mary George Johnson Antithrombotic agents
US6090843A (en) * 1997-08-11 2000-07-18 Eli Lilly And Company Benzothiophenes compounds which have useful pharmaceutical activity
US6096781A (en) * 1997-11-14 2000-08-01 Eli Lilly And Company 2-arylbenzo[B]thiophenes useful for the treatment of estrogen deprivation syndrome
ID24978A (id) * 1997-11-14 2000-08-31 Lilly Co Eli 2-ARYL-3-AROYLBENZO (b) THIOPHENES BERGUNA UNTUK PENGOBATAN SINDROM DEPRIVASI ESTROGEN
US6258826B1 (en) 1998-10-13 2001-07-10 Eli Lilly And Company Pharmaceutical formulations and applications thereof for the treatment of estrogen deprivation syndrome
FR2813307B1 (fr) * 2000-08-23 2002-11-08 Sanofi Synthelabo Aminoalkenylbenzoyl-benzofurannes ou benzothiophenes, leur procede de preparation et les compositions les contenant
ES2236536T3 (es) * 2001-05-22 2005-07-16 Eli Lilly And Company Derivados tetrahidroquinolino para la inhibicion de enfermedades asociadas con la privacion de estrogenos o con una respuesta fisiologica aberrante a estrogenos endogenos.
EP1395563B1 (en) 2001-05-22 2006-03-29 Eli Lilly And Company 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods
US7306283B2 (en) 2002-11-21 2007-12-11 W.E.T. Automotive Systems Ag Heater for an automotive vehicle and method of forming same
DE112011101808T5 (de) 2010-05-27 2013-05-16 W.E.T.Automotive Systems Ltd. Heizeinrichtung für ein Kraftfahrzeug und Verfahren zu deren Herstellung
US9191997B2 (en) 2010-10-19 2015-11-17 Gentherm Gmbh Electrical conductor
DE102012000977A1 (de) 2011-04-06 2012-10-11 W.E.T. Automotive Systems Ag Heizeinrichtung für komplex geformte Oberflächen
US10201039B2 (en) 2012-01-20 2019-02-05 Gentherm Gmbh Felt heater and method of making
DE102012017047A1 (de) 2012-08-29 2014-03-06 W.E.T. Automotive Systems Ag Elektrische Heizeinrichtung
DE102012024903A1 (de) 2012-12-20 2014-06-26 W.E.T. Automotive Systems Ag Flächengebilde mit elektrischen Funktionselementen
RS57106B1 (sr) 2013-02-19 2018-06-29 Novartis Ag Derivati benzotiofena i njihove kompozicije kao selektivni degraderi estrogenskog receptora

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3274213A (en) 1961-09-05 1966-09-20 Upjohn Co Alkoxy-substituted 2-phenyl-1-(tertiary-aminoalkoxy)phenyl-3, 4-dihydronaphthalenes
US3396169A (en) 1966-10-26 1968-08-06 Upjohn Co Substituted 2-phenyl-1-(tertiary-aminoalkoxy) phenyl-3, 4-dihydronaphthalenes
US3862232A (en) 1963-07-03 1975-01-21 Upjohn Co 1-(p-hydroxyphenyl)-2-phenyl-6-(2-diethylaminoethoxy)-3,4-dihydronaphthalene and the salts thereof
US3313853A (en) 1963-10-16 1967-04-11 Upjohn Co 2-(tertiaryaminoalkoxyphenyl)-3, 4-dihydronaphthalenes and 2-(tertiaryaminoalkoxyphenyl) -3, 4- dihydro -1(2h)-naphthalenones
US3293263A (en) 1963-12-09 1966-12-20 Upjohn Co Diphenylbenzocycloalkenes
US3320271A (en) 1964-06-01 1967-05-16 Upjohn Co 1, 2-diphenyl-3, 4-dihydronaphthalenes and 2, 3-diphenylindenes
DE1300575B (de) 1965-05-21 1969-08-07 Bristol Myers Co Benzo[b]thiophene
US3394125A (en) 1965-10-23 1968-07-23 Bristol Myers Co 2-phenyl-3-tertiary-aminoalkoxy phenyl-and corresponding tertiaryaminoalkyl thio benzfurans substituted in the benzo nucleus with an alkoxy or tertiaryamino alkoxy or alkylthio group
US3483293A (en) 1967-12-15 1969-12-09 Upjohn Co Method for controlling birds and rodents
US3567737A (en) 1968-01-02 1971-03-02 Upjohn Co Derivatives of (2-cycloalkyl-1-phenyl-3,4-dihydronaphthalenes and) 2 - cycloalkyl - 1 - phenyl - 1,2,3,4 - tetrahydro-naphthalenes
US4230862A (en) 1975-10-28 1980-10-28 Eli Lilly And Company Antifertility compounds
US4133814A (en) 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4418068A (en) 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4380635A (en) 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
GB8311678D0 (en) 1983-04-28 1983-06-02 Ici Plc Phenol derivatives
US5395842A (en) 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
US5254568A (en) 1990-08-09 1993-10-19 Council Of Scientific & Industrial Research Benzopyrans as antiestrogenic agents
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
US6756388B1 (en) * 1993-10-12 2004-06-29 Pfizer Inc. Benzothiophenes and related compounds as estrogen agonists
US5391557A (en) * 1993-10-15 1995-02-21 Eli Lilly And Company Methods for the treatment of peri-menopausal syndrome
US5480904A (en) * 1993-10-28 1996-01-02 Eli Lilly And Company Methods for inhibiting uterine fibrosis
US5514704A (en) * 1995-03-13 1996-05-07 Eli Lilly And Company Benzothiophenes to inhibit leukotrienes
US5532382A (en) * 1995-03-13 1996-07-02 Eli Lilly And Company Benzothiophenes substituted at the 3-carbonyl
JP4111352B2 (ja) 1996-05-21 2008-07-02 新日鐵住金ステンレス株式会社 ステンレス鋼の高清浄化精錬法

Also Published As

Publication number Publication date
PT842169E (pt) 2001-04-30
CA2220991A1 (en) 1997-01-16
DE69611452T2 (de) 2001-06-13
EP0842169B1 (en) 2001-01-03
EP0842169A4 (en) 1998-10-14
ES2153113T3 (es) 2001-02-16
ATE198477T1 (de) 2001-01-15
US6440958B1 (en) 2002-08-27
JPH11508269A (ja) 1999-07-21
EP0842169A1 (en) 1998-05-20
GR3035492T3 (en) 2001-05-31
WO1997001549A1 (en) 1997-01-16
DE69611452D1 (de) 2001-02-08
AU6335496A (en) 1997-01-30

Similar Documents

Publication Publication Date Title
DK0842169T3 (da) Benzothiophenforbindelser
AU1373499A (en) Use of 9-deoxy-2', 9-alpha-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) -13,14-dihydro- prostaglandin f1 to treat peripheral vascular disease
TR199902538T2 (xx) Yeni bile�imler.
BG107537A (en) Method for the inhibition of human tnf alpha activity and its application
EE9700267A (et) a1L- agonistide kasutamine uriiniinkontinentsuse raviks
SE9502893D0 (sv) Användning av kollagenas
AR038429A2 (es) Compuestos 15-alquil-16-hidroxilo de marcfortina
FI930377A0 (fi) Reducering kvaeveoxider under anvaendning av ureahydrolysat
MY111201A (en) New imidazopyridines
EP0786995A4 (da)
DE69534908D1 (de) Verwendung von statin zur behandlung von hauterkrankungen
HUP0001014A2 (hu) Gasztrointesztinális lipáz inhibitorok felhasználása
ES2157992T3 (es) Alcoxi-alquil-carbamatos de imidazo(1,2-a)piridinas.
DK0869965T3 (da) Steroidnitritesterderivater anvendelige som antiinflammatoriske lægemidler
DE69611598T2 (de) Azoderivate von 5-aminosalicylsäure zur behandlung von enzündlichen darmerkrankungen
AU4376396A (en) Use of andrographolide compounds to treat or prevent pathogenicity of diseases
FI962480A0 (fi) Bisnoralkoholin muuntaminen bisnoraldehydiksi
BR9611472A (pt) Compostos de di-terc-butilfenol contendo enxofre úteis como agentes antiinflamatórios
NO993627L (no) Anvendelse av en forbindelse for fremstilling av et legemiddel
DE69736180D1 (de) Behandlung von manischen erkrankungen
ATE222762T1 (de) 4-hydroxycoumarin-3-carboxamide für die behandlung von nicht-insulin-abhängigen diabetes mellitus
ITTO930806A1 (it) Purificazione dell' 1, 1-dicloro-1-fluoroetano.
WO1989005644A3 (fr) Thienotricyclene
ID26405A (id) Pemurnian karboksaldehida
NO954115L (no) Anvendelse av ceruletid-dietylaminsalt ved behandling av psoriasis